SEP 07, 2016 12:00 PM PDT

Cord Blood Compound To Treat Inflammation

WRITTEN BY: Kara Marker
A compound found in newborns is thought to have the ability to treat excessive inflammation, which could be lifesaving in cases of sepsis. However, the compound disappears from newborn circulation after two weeks of life. 
Infection fighting cells from umbilical cord blood (left) and circulating blood three days after birth (right) from the same prematurely born baby.
First found in umbilical cord blood, the compound works by inhibiting the production of neutrophil extracellular traps (NETs). Thus, the compound is reasonably referred to as neonatal NET inhibitor factor, or nNIF. 

NETs have the ability to damage blood vessels and organs during sepsis, but their intended role is simply to protect the body from pathogens. While a healthy person might have normal-functioning NETs, a person exposed to nicotine from cigarette smoke or someone with sepsis could contain the types of NETs that malfunction, causing excessive inflammatory damage. As for nicotine exposure, the chemical stimulates neutrophils to release NETs and reactive oxygen species. In the present study, researchers think that inhibiting NETs when they “go rogue” might help treat sepsis.

"nNIF is offering insights into how to keep the inflammatory response within prescribed limits,” said lead author Christian Con Yost, MD.

After understanding the ability of nNIFs to inhibit the production NETs, scientists from the University of Utah set out to conduct further tests confirming nNIFs’ ability to control sepsis. Using groups of mice models of sepsis, all from different causes, the researchers used nNIFs to see if they could heal some of the mice. Only 20 mice survived longer than a couple of days without nNIF treatment, but the mice who did receive nNIF were three times as likely to survive.

It makes sense that nNIF remains in the circulation of newborns, because the first weeks after birth a newborn’s immune system is still building up strength and the gut microbiome is only starting to grow. Yost said that the “transient nature” of nNIF in newborn blood is connected to the tight control of inflammation during the first two weeks of a newborn’s life, certainly a vulnerable time.

"The beginning of life is a delicate balance," Yost said. "Our work is showing that it is important to have the right defenses, but they have to be controlled."

The placenta has a similar compound to nNIF, but it’s less potent. 

The current study was recently published in The Journal of Clinical Investigation.
 


Source: University of Utah Health Sciences
Image: Mark Cody/Diana Lim
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 31, 2019
Cancer
OCT 31, 2019
Unpacking lactate's role in the Warburg effect
In a recent issue of Nature, the findings of one study made a particularly big splash: how and why cancer cells use energy differently than healthy cells. ...
NOV 12, 2019
Immunology
NOV 12, 2019
Allergy Shots May Work for Kids with Pollen Food Allergy Syndrome
It’s not common for young children to develop pollen food allergy syndrome (PFAS), but for those that do, there’s not too much parents can do o...
NOV 19, 2019
Microbiology
NOV 19, 2019
Ketogenic Diet Appears to Help Protect Against the Flu
The ketogenic diet forces the body to use stored fat as fuel instead of carbohydrates; the fat gets broken down into ketone bodies....
FEB 17, 2020
Immunology
FEB 17, 2020
Another HIV vaccine attempt fizzles out
Years of work and over $100 million in study costs have been abandoned after an HIV-vaccine tested in South Africa failed to protect treated individuals ag...
MAR 05, 2020
Drug Discovery & Development
MAR 05, 2020
Human Stem Cells Cure Type 1 Diabetes in Mice
In the US alone, around 187,000 children and adolescents have Type 1 diabetes, alongside 1.4 million people aged 20 and over. Managing their condition with...
MAR 23, 2020
Drug Discovery & Development
MAR 23, 2020
Is Fast-Tracking Vaccines for Coronavirus Really Such a Good Idea?
Donald Trump has called on researchers to “slash red tape like nobody has even done it before” to accelerate the development of vaccines for th...
Loading Comments...